- Home
- » Tags
- » Extrapyramidal symptoms
Top View
- Management of Movement Disorders And
- Extrapyramidal Side Effects of Antipsychotics: Prevalence and Risk Factors
- Review of Quetiapine Side Effects
- Neuroleptic Malignant Syndrome
- Antidepressants and Movement Disorders
- Escitalopram-Induced Extrapyramidal Symptoms
- Revista Brasileira De Psiquiatria Official Journal of the Brazilian Psychiatric Association Psychiatry Volume 34 • Number 4 • December/2012
- Tofranil-PM™ (Imipramine Pamoate) Capsules (75 Mg, 100 Mg, 125 Mg and 150 Mg)
- Antipsychotics and Neuroleptic Malignant Syndrome
- Black-Box Warnings for First-Generation Antipsychotics
- Quetiapine and Extrapyramidal Effects
- Amisulpride Vs. Risperidone in Chronic Schizophrenia
- Treatment Recommendations for Extrapyramidal Side Effects Associated with Second-Generation Antipsychotic Use in Children and Youth
- Atypical Antipsychotic Medications: Use in Adults
- SURMONTIL (Trimipramine Maleate) Is 5-(3-Dimethylamino-2-Methylpropyl)-10,11-Dihydro-5H-Dibenz (B,F) Azepine Acid Maleate (Racemic Form)
- The Link Between Amitriptyline and Movement Disorders: Clinical Profile and Outcome
- Induced Extrapyramidal Symptoms
- New Zealand Data Sheet
- Atypical Antipsychotics Comparison Guide
- PRODUCT MONOGRAPH SURMONTIL® (Trimipramine)
- Pharmacogenetic Analysis
- Irreversible Side Effects of Psychotropic Medication Policy Extrapyramidal Side Effects, Tardive Dyskinesia Jaundice, and Neuroleptic Malignant Syndrome
- Extrapyramidal Symptoms in Patients Treated with Antipsychotic Drugs
- Diphenhydramine for Acute Extrapyramidal Symptoms After Propofol Administration James Sherer, BA, Tomas Salazar, BE, Kevin B
- Chapter 161 – Antipsychotics
- Recognition and Management of Antipsychotic-Induced Parkinsonism in Older Adults: a Narrative Review